Jens V.
- Country
- Germany
- Department
- Neurologische Klinik und Poliklinik
Research Overview
- Efficacy and Safety of NIO752 in Participants with Progressive Supranuclear Palsy Richardson Syndrome: A Phase III Randomized, Placebo-Controlled Study
- Efficacy and Safety Evaluation of BIIB122 in a Randomized, Double-Blind, Placebo-Controlled Phase 2b Study in Parkinson's Disease Patients
- Evaluation of Fasudil Hydrochloride Safety, Tolerability, and Efficacy in Idiopathic Parkinson's Disease Patients
Data & Insights
Has run more than one trial at 72 of 154 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in the treatment and research of Parkinson's Disease, with particular emphasis on exploring innovative therapeutic approaches for managing motor symptoms and disease progression.
- Motor Symptom Management
- Disease Modification Strategies
- Novel Therapeutic Development
Their research encompasses evaluating various treatment modalities including ROCK inhibitors and gene therapy approaches.
Therapeutic Innovation
The investigator focuses on advancing neurological treatments through the evaluation of cutting-edge therapeutic agents, including AAV2-GDNF gene therapy and novel pharmaceutical compounds.
- Gene Therapy Applications
- Neuroprotective Strategies
- Drug Safety Evaluation
Their work involves assessing both symptomatic treatments and potential disease-modifying interventions.
Clinical Assessment
The investigator specializes in conducting comprehensive evaluations of therapeutic efficacy and safety profiles in neurological conditions, particularly focusing on idiopathic Parkinson's disease.
- Safety Profile Assessment
- Tolerability Studies
- Treatment Response Evaluation
Their expertise includes the systematic assessment of both established and experimental therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.